Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001104659-23-067591

Options or other derivatives

  • Director acquired 14,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
RA CAPITAL MANAGEMENT, L.P. Director 2023-05-31 Grant or award · Stock Option (Right to Buy) +14,500 14,500 I
Loading xslF345X04/tm2317680-1_4seq1.xml…